Objective On high salt intake, Dahl salt-sensitive rats develop cardiac hyp
ertrophy disproportionate to the degree of hypertension. In the present stu
dies, we assessed whether the cardiac hypertrophy induced by high salt depe
nds on the development of hypertension per se, and leads to over-activity o
f the cardiac renin-angiotensin system (RAS),
Methods Cardiac angiotensin converting enzyme (ACE) mRNA and activity, card
iac and plasma angiotensin I and II (AngI, II), as well as plasma renin act
ivity (PRA) were assessed in Dahl salt-sensitive (Dahl S) and salt-resistan
t (Dahl R) rats on high (1370 mu mol/g food) or regular salt (120 mu mol/g
food) diet for 2-5 weeks, Cardiac ACE and hypertrophic response in Dahl S o
n high salt were also assessed after central blockade of sympathetic hypera
ctivity and hypertension.
Results In Dahl S rats, ACE mRNA and activity of the left ventricle (LV) in
creased markedly after 4-5 weeks of high salt diet compared with Dahl S on
the central diet and Dahl R on either diet, Chronic intra-cerebroventricula
r treatment with Fab fragments blocking brain 'ouabain' prevented the hyper
tension by high salt in Dahl S rats but did not affect the salt-induced inc
reases in LV weight or in LV ACE mRNA and activity. On regular salt diet, D
ahl S rats demonstrated significantly lower cardiac AngI and AngII than Dah
l R rats. However, high salt intake did not cause significant changes in ca
rdiac AngI and II in either strain, On regular salt diet, PRA, plasma AngI
and II were all significantly lower in Dahl S versus R, in Dahl S rats, hig
h salt did not cause further decreases of the already low PRA or plasma Ang
I and II.
Conclusions These data indicate a low activity of both circulatory and card
iac RAS in Dahl S versus R rats, The marked cardiac hypertrophy and increas
e in cardiac ACE mRNA and activity induced by high salt in Dahl S do not de
pend on the increase in blood pressure, High salt intake did not increase c
ardiac AngII in Dahl S, suggesting that the increase in ACE mRNA and activi
ty may be relevant for non-angiotensinergic mechanisms involved in cardiac
hypertrophy, J Hypertens 2000, 18:1319-1326 (C) Lippincott Williams & Wilki
ns.